ArticleAnnals of biomedical engineering2025
DeepSeek's Readiness for Medical Research and Practice: Prospects, Bottlenecks, and Global Regulatory Constraints.
Article in Annals of biomedical engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Applications of DeepSeek in Medicine: Bibliometric Analysis and Scoping Review.Journal of medical Internet research · 2026Article
- Assessment of Stage Two Hypertension Treatment Plans Written by Generative AI.Journal of clinical medicine · 2026Article
- Comparative performance evaluation of large language models in answering esophageal cancer-related questions: a multi-model assessment study.Frontiers in digital health · 2025Article
- Application and challenges of DeepSeek in primary care in China.Frontiers in public health · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
DeepSeek, an open-source multimodal Large Language Model (LLM), was launched by the Chinese startup (Hangzhou DeepSeek Artificial Intelligence Basic Technology Research Co., Ltd.). Despite the lack of advanced artificial intelligence (AI) chips, the performance of its milestone version, "DeepSeek-V3," has set an unprecedented benchmark among LLMs, surpassing existing models. Notably, the opportunity to deploy this model in the local system helps build better-performing "distilled versions" suitable for medical research (hypothesis generation, drafting patient consent forms and biostatistical analysis, etc.) and clinical practice (differential diagnosis from symptom clusters, current guideline-based treatment protocol design, interactive medical training, personalized patient education, etc.). However, privacy and security risks, ethical uncertainties, and diversified global AI regulations hinder its potential for sustainable integration into real-world applications.
Indexed as
Identifiers
40272697What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.